This talk will discuss an emerging intellectual property aspect of drug repurposing – not the mechanism by which novel methods of treatment or even formulations are patented, but how modifying properties such as drug delivery can create brand new classes of intellectual property. We will discuss how such intellectual property can add tremendous value to a pharmaceutical asset and how resulting patents are prosecuted and litigated. As drug development timelines lengthen and with the advent of machine-learning methods to tease out clinical signals from older compounds, the time is ripe to consider new methods for obtaining intellectual property on older assets.

This seminar is divided into two parts. In part I, on October 14th at 11:30am Pacific, we will introduce these new trends in drug repurposing. In part II, on October 28th at 11:30am Pacific, we will go into more detail on how to take advantage of these trends.